Floatz logo

L-METHIONINE

Hodgkin Lymphoma

St. Jude Children's Research HospitalSmall moleculePhase 2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
65/ 100

Competitive context

149 Active assets in the Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Fred Hutchinson Cancer Center
Phase 3BBB
CYCLOSPORIN A
City of Hope Medical Center
Phase 3BBB
Cytosin-Arabinosid
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BBB
Carboplatin
St. Petersburg State Pavlov Medical University
Phase 2BBB
METHOTREXATE
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BBB

View all 50 →

Same molecule, other indications

L-METHIONINE is also rated in:

major depressive disorderDormant
BB
Indicative ·
69 / 100
View asset →
Glioblastoma MultiformeDormant
B
Indicative ·
57 / 100
View asset →
Ewing sarcomaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →